Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

TG Therapeutics Inc (TGTX)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow TG's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
13.82 -0.18    -1.29%
16:00:00 - Closed. Currency in USD ( Disclaimer )
After Hours
13.88
+0.06
+0.43%
19:59:59 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 3,017,797
  • Bid/Ask: 13.88 / 14.05
  • Day's Range: 13.55 - 14.13
TG 13.82 -0.18 -1.29%

TG Therapeutics Inc Company Profile

 
Get an in-depth profile of TG Therapeutics Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

245

Equity Type

ORD

TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally. It provides BRIUMVI, an anti-CD20 monoclonal antibody for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults. The company’s development pipeline comprises Umbralisib, an oral inhibitor of PI3K-delta inhibitor for the treatment of adult patients with relapsed or refractory marginal zone lymphoma and follicular lymphoma; TG-1701 is an orally available and covalently bound Bruton’s tyrosine kinase (BTK) inhibitor that exhibits selectivity to BTK in vitro kinase screening; and TG-1801, a bispecific CD47 and CD19 antibody. Its research pipeline includes various investigational medicines. The company has license agreements with LFB Biotechnologies S.A.S; GTC Biotherapeutics; LFB/GTC LLC; Ildong Pharmaceutical Co. Ltd.; Rhizen Pharmaceuticals, S A. for the development and commercialization of umbralisib; Jiangsu Hengrui Medicine Co.; and Novimmune SA, as well as collaboration agreement with Checkpoint Therapeutics, Inc. for the development and commercialization of anti-PD-L1 and anti-GITR antibody research programs in the field of hematological malignancies. TG Therapeutics, Inc. was incorporated in 1993 and is based in Morrisville, North Carolina.

Contact Information

Address 3020 Carrington Mill Blvd. Suite 475
Morrisville, 27560
United States
Phone 212 554 4484
Fax 212 554 4531

Top Executives

Name Age Since Title
Laurence N. Charney 75 2012 Lead Independent Director
Daniel Hume 56 2015 Independent Director
Michael S. Weiss 57 2011 Chairman, CEO & President
Yann Echelard 59 2012 Independent Director
Kenneth Hoberman 58 2014 Independent Director
Sagar Lonial 56 2020 Independent Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

TGTX Comments

Write your thoughts about TG Therapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
James Love
James Love May 15, 2023 3:14PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
My PT is 3.
André Bulten
André Bulten May 05, 2023 7:17AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
38$ to day is possible
André Bulten
André Bulten May 04, 2023 8:43AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Fly us to 100 $
JAMES PARKMAN
JAMES PARKMAN Jan 10, 2023 3:22PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Europe is next, to the moon.
Carl Michael Ashanti
Carl Michael Ashanti Dec 28, 2022 2:28PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
boom!!
Sallad Skit
Sallad Skit Dec 28, 2022 12:45PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Any time now...
Max Joseph
Max Joseph Feb 22, 2022 5:36PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
wow, very big POS
Ernest Bollero
Ernest Bollero Jan 07, 2019 1:56AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
starting to wonder, who the real longs are on ST.
Ernest Bollero
Ernest Bollero Jan 07, 2019 1:00AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Trying to get the 2020 club members, to post on this forum …..
Ernest Bollero
Ernest Bollero Jan 07, 2019 12:57AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
ivosplash, ian ….. you there ?
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email